US Equity
RGNX
— REGENXBIO INC.REGENXBIO Inc. is a clinical-stage biotechnology company that develops gene therapy treatments using its proprietary adeno-associated virus gene delivery platform.
💰 Market cap: $614.53M📍 9804 Medical Center Drive, ROCKVILLE, MD, 20850 US🏷️ Biotechnology & Medical Research💵 Previous close: $9.73🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $9.73 |
| 2026-07-23 | $10.25 |
| 2026-07-22 | $10.20 |
| 2026-07-21 | $10.34 |
| 2026-07-20 | $10.32 |
| 2026-07-17 | $9.89 |
| 2026-07-16 | $11.20 |
| 2026-07-15 | $12.27 |
| 2026-07-14 | $12.29 |
| 2026-07-13 | $12.75 |
| 2026-07-10 | $13.95 |
| 2026-07-09 | $15.65 |
| 2026-07-08 | $15.23 |
| 2026-07-07 | $15.02 |
| 2026-07-06 | $14.83 |
| 2026-07-02 | $13.28 |
| 2026-07-01 | $13.09 |
| 2026-06-30 | $11.98 |
| 2026-06-29 | $11.83 |
| 2026-06-26 | $10.48 |
| 2026-06-25 | $10.24 |
| 2026-06-24 | $9.97 |
| 2026-06-23 | $9.95 |
| 2026-06-22 | $9.07 |
| 2026-06-18 | $7.80 |
| 2026-06-17 | $7.90 |
| 2026-06-16 | $6.93 |
| 2026-06-15 | $7.07 |
| 2026-06-12 | $6.66 |
| 2026-06-11 | $6.28 |
| 2026-06-10 | $6.13 |
| 2026-06-09 | $6.34 |
| 2026-06-08 | $6.13 |
| 2026-06-05 | $6.08 |
| 2026-06-04 | $6.88 |
| 2026-06-03 | $6.69 |
| 2026-06-02 | $6.52 |
| 2026-06-01 | $7.14 |
| 2026-05-29 | $7.01 |
| 2026-05-28 | $6.89 |
| 2026-05-27 | $6.69 |
| 2026-05-26 | $6.31 |
| 2026-05-22 | $6.35 |
| 2026-05-21 | $6.75 |
| 2026-05-20 | $5.97 |
| 2026-05-19 | $5.66 |
| 2026-05-18 | $5.65 |
| 2026-05-15 | $5.72 |
| 2026-05-14 | $6.25 |
| 2026-05-13 | $10.04 |
| 2026-05-12 | $10.24 |
| 2026-05-11 | $10.08 |
| 2026-05-08 | $10.55 |
| 2026-05-07 | $10.42 |
| 2026-05-06 | $10.22 |
| 2026-05-05 | $9.22 |
| 2026-05-04 | $9.39 |
| 2026-05-01 | $9.12 |
| 2026-04-30 | $8.97 |
| 2026-04-29 | $8.40 |
| 2026-04-28 | $8.69 |